This webinar explores recent advancements in crystal screening and characterization for pharmaceutical development. In the first segment, researchers from NGK Corporation outline a new crystal polymorphism screening approach that utilizes infrared radiation technology to enhance the detection of previously unidentified crystalline forms. Experimental case studies will illustrate how this method can support more reliable and efficient drug development. In the second segment, Professor Etsuo Yonemochi from the International University of Health and Welfare will discuss the relationship between crystallization conditions and crystal morphology, examining how these factors influence properties such as dissolution, wettability, and manufacturability. His presentation will also cover the use of molecular simulations to assess formulation-related characteristics.
This webinar will provide:
Who should attend:
Please check the highlighted fields and try again.